ArriVent BioPharma, Inc. AVBP Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.02B.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s market capitalization?
- ArriVent BioPharma, Inc. (AVBP) reported market capitalization of $1.02B in Q1 2026.
- How has ArriVent BioPharma, Inc.'s market capitalization changed year-over-year?
- ArriVent BioPharma, Inc.'s market capitalization increased by 62.1% year-over-year, from $628.96M to $1.02B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.